Pemetrexed combined with dual immune checkpoint blockade enhances cytotoxic T lymphocytes against lung cancer

Chemotherapy, in combination with immune checkpoint blockade (ICB) targeting to programmed death‐1 (PD‐1) or its ligand PD‐L1, is one of the first‐line treatments for patients with advanced non–small‐cell lung cancer (NSCLC). However, a large proportion of patients, especially those with PD‐L1 negat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mei‐Chih, Hung, Meng‐Yu, Pan, Chih‐Ming, Huang, Shi‐Wei, Jan, Chia‐Ing, Li, Yu‐Hsuan, Chiu, Shao‐Chih, Cho, Der‐Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323078/
https://www.ncbi.nlm.nih.gov/pubmed/37017116
http://dx.doi.org/10.1111/cas.15806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323078/
https://www.ncbi.nlm.nih.gov/pubmed/37017116
http://dx.doi.org/10.1111/cas.15806

Ejemplares similares